MAI-CHI HA: Open Payments
NPI 1144316514 · ANNANDALE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $46 · 2025 $367
Food & beverage: $256Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $162 |
| Alkermes, Inc. | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: ARISTADA, UZEDY, INVEGA SUSTENNA, ABILIFY ASIMTUFII, CAPLYTA, COBENFY, INGREZZA, REXULTI.
Industry payments across VA — which companies pay providers there.
